REGULUS THERAPEUTICS INC's ticker is and the CUSIP is 75915K309. A total of 26 filers reported holding REGULUS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 555,555 | $470,833 | 0.14% |
| Sarissa Capital Management LP | 185,183 | $156,943 | 0.02% |
| FEDERATED HERMES, INC. | 2,904,826 | $2,463,292 | 0.01% |
| GROUP ONE TRADING, L.P. | 492 | $417 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 74,573 | $63,200 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 40,700 | $34,595 | 0.00% |
| UBS Group AG | 1,738 | $1,474 | 0.00% |
| ROYAL BANK OF CANADA | 198 | $0 | 0.00% |
| VANGUARD GROUP INC | 282,660 | $239,554 | 0.00% |
| VICTORY CAPITAL MANAGEMENT INC | 221,506 | $187,726 | 0.00% |